Design, Synthesis, Molecular Docking, ADMET Prediction and Biological Evaluation of Novel 1,4,5-Triphenyl-Substituted Pyrrole Derivatives as Potential Anti-inflammatory and Anticancer Agents
Abstract
Pyrrole based heterocyclic compounds constitute an important class of pharmacologically active molecules owing to their broad spectrum of biological activities and favorable structural characteristics. In the present study, a series of novel 1,4,5-triphenyl-substituted pyrrole derivatives were designed and synthesized using both conventional reflux and microwave-assisted synthetic methodologies. Microwave-assisted method significantly reduced the reaction time and enhanced product yield compared to the traditional protocol. The synthesized compounds were characterized by Fourier-transform infrared spectroscopy (FT-IR), proton nuclear magnetic resonance (1H NMR), carbon-13 nuclear magnetic resonance (13C NMR) and mass spectrometry which confirmed the formation of desired pyrrole derivatives. The biological potential of the synthesized molecules was investigated by molecular docking against cyclooxygenase (COX; PDB ID: 6COX) and antibacterial target protein (PDB ID: 3G75). The compound B (-8.4 kcal/mol) showed the best binding affinity towards COX receptor which is very close to diclofenac while compound E (-7.1 kcal/mol) showed the highest interaction towards antibacterial target which is similar to streptomycin. The experimental biological evaluation also indicated significant anti-inflammatory activity especially for the o-chloroaniline derivative with 78.77% inhibition of protein denaturation at 1000 µg/mL. Antimicrobial screening revealed moderate activity against Staphylococcus aureus where compound E exhibited the largest zone of inhibition (21 mm). The in vitro anticancer evaluation against MDA-MB-4355 cells revealed that compound C was the most potent derivative with 65% growth inhibition comparable to 5-fluorouracil. ADMET prediction revealed good gastrointestinal absorption, good bioavailability and promising drug-likeness for most of the synthesized compounds.